论文部分内容阅读
目的观察通心络联合倍他司汀治疗椎—基底动脉供血不足(VBI)性眩晕的临床疗效。方法将60例VBI性眩晕患者随机分为2组。治疗组30例给予通心络胶囊4粒口服,每天3次;倍他司汀8mg口服,每天3次。对照组30例仅口服倍他司汀8mg,每天3次。治疗后观察2组临床疗效。结果治疗组总有效率为93.3%高于对照组的73.3%,差异有统计学意义(P<0.05)。2组治疗中未出现任何不良反应。结论通心络联合倍他司汀治疗VBI性眩晕疗效显著,安全性好,值得临床推广应用。
Objective To observe the clinical efficacy of Tongxinluo combined with Betatine in treatment of vertigo caused by vertebrobasilar insufficiency (VBI). Methods Sixty patients with VBI vertigo were randomly divided into two groups. Thirty patients in the treatment group were given Tongxinluo capsule 4 capsules orally, 3 times a day; Betamethasone 8mg orally 3 times a day. In the control group, 30 patients received betahistine only 3 times a day. Two groups were observed after treatment efficacy. Results The total effective rate in the treatment group was 93.3%, which was significantly higher than that in the control group (73.3%, P <0.05). No adverse reactions occurred in the two groups during treatment. Conclusion Tongxinluo combined with Betalistine treatment of VBI vertigo significant effect, good safety, worthy of clinical application.